Farther Finance Advisors’s Tvardi Therapeutics TVRD Stock Holding History

Farther Finance Advisors’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30	Sell	16 -7	-30%	-$22	﹤0.01%	5887
2026 Q1	$69	Buy	23 +20	+667%	+$78	﹤0.01%	5545
2025 Q4	$13	Hold	3	–	–	﹤0.01%	5409
2025 Q3	$117	Hold	3	–	–	﹤0.01%	4806
2025 Q2	$70	Hold	3	–	–	﹤0.01%	4342
2025 Q1	$44	Buy	+3	New	+$45	﹤0.01%	4137
2024 Q2	–	Sell	-25	Closed	-$596	–	3939
2024 Q1	$834	Buy	25 +24	+2,400%	+$622	﹤0.01%	2839
2023 Q4	$27	Buy	+1	New	+$41	﹤0.01%	3438

Other funds holding TVRD

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors's TVRD Position: Q2 2026 in Review

Farther Finance Advisors reduced its Tvardi Therapeutics (TVRD) stake by 30% in Q2 2026, selling an estimated $22 and leaving 16 shares worth $30. The position accounts for ﹤0.01% of the portfolio, ranked #5887.

Farther Finance Advisors first reported a position in TVRD in Q4 2023 and has held it in 8 quarters since. The position peaked at $834 in Q1 2024. 4 funds tracked by Wall St. Rank hold TVRD as of Q2 2026.

Farther Finance Advisors held 16 shares of Tvardi Therapeutics worth $30 as of Q2 2026.
Farther Finance Advisors sold 7 Tvardi Therapeutics shares in Q2 2026, an estimated $22.
Tvardi Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5887 holding.
Farther Finance Advisors first reported a position in Tvardi Therapeutics in Q4 2023 and has held it in 8 quarters since.
Farther Finance Advisors's Tvardi Therapeutics position peaked at $834 in Q1 2024.
4 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.